Literature DB >> 11133506

Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke.

K Takeyama1, B Jung, J J Shim, P R Burgel, T Dao-Pick, I F Ueki, U Protin, P Kroschel, J A Nadel.   

Abstract

Mucus hypersecretion from hyperplastic airway goblet cells is a hallmark of chronic obstructive pulmonary disease (COPD). Although cigarette smoking is thought to be involved in mucus hypersecretion in COPD, the mechanism by which cigarette smoke induces mucus overproduction is unknown. Here we show that activation of epidermal growth factor receptors (EGFR) is responsible for mucin production after inhalation of cigarette smoke in airways in vitro and in vivo. In the airway epithelial cell line NCI-H292, exposure to cigarette smoke upregulated the EGFR mRNA expression and induced activation of EGFR-specific tyrosine phosphorylation, resulting in upregulation of MUC5AC mRNA and protein production, effects that were inhibited completely by selective EGFR tyrosine kinase inhibitors (BIBX1522, AG-1478) and that were decreased by antioxidants. In vivo, cigarette smoke inhalation increased MUC5AC mRNA and goblet cell production in rat airways, effects that were prevented by pretreatment with BIBX1522. These effects may explain the goblet cell hyperplasia that occurs in COPD and may provide a novel strategy for therapy in airway hypersecretory diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11133506     DOI: 10.1152/ajplung.2001.280.1.L165

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  67 in total

Review 1.  Kallikreins - The melting pot of activity and function.

Authors:  Magdalena Kalinska; Ulf Meyer-Hoffert; Tomasz Kantyka; Jan Potempa
Journal:  Biochimie       Date:  2015-09-25       Impact factor: 4.079

Review 2.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

Review 3.  State of the art. Bronchiolitis in chronic obstructive pulmonary disease.

Authors:  James C Hogg
Journal:  Proc Am Thorac Soc       Date:  2006-08

4.  Distinctive epidermal growth factor receptor/extracellular regulated kinase-independent and -dependent signaling pathways in the induction of airway mucin 5B and mucin 5AC expression by phorbol 12-myristate 13-acetate.

Authors:  Daphne Yuan-Chen Wu; Reen Wu; Sekhar P Reddy; Yong Chan Lee; Mary Mann-Jong Chang
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

5.  MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium.

Authors:  Maria E Monzon; Rosanna Malbrán Forteza; S Marina Casalino-Matsuda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

Review 6.  Regulation of airway mucin gene expression.

Authors:  Philip Thai; Artem Loukoianov; Shinichiro Wachi; Reen Wu
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

7.  MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway.

Authors:  Un-Hwan Ha; Jae Hyang Lim; Hyun-Joong Kim; Weihui Wu; Shouguang Jin; Haidong Xu; Jian-Dong Li
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

8.  Vanadium pentoxide (V(2)O(5)) induced mucin production by airway epithelium.

Authors:  Dongfang Yu; Dianne M Walters; Lingxiang Zhu; Pak-Kei Lee; Yin Chen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-29       Impact factor: 5.464

9.  Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells.

Authors:  Matt X G Shao; Iris F Ueki; Jay A Nadel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

Review 10.  Emerging role of MAP kinase pathways as therapeutic targets in COPD.

Authors:  Becky A Mercer; Jeanine M D'Armiento
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.